Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Newly Diagnosed Glioblastoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT07326566
What this trial is testing

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Who this might be right for
Glioblastoma (GBM)Newly Diagnosed GlioblastomaGBM+4 more
Black Diamond Therapeutics, Inc. 162
Early research (Phase 1)Active Not RecruitingNCT03535350
What this trial is testing

Ibrutinib With Radiation and Temozolomide in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Case Comprehensive Cancer Center 36
Large-scale testing (Phase 3)UnknownNCT00278278
What this trial is testing

Combination Chemotherapy and Radiation Therapy With or Without Methotrexate in Treating Young Patients With Newly Diagnosed Gliomas

Who this might be right for
Brain and Central Nervous System Tumors
German Society for Pediatric Oncology and Hematology GPOH gGmbH 150
Early research (Phase 1)UnknownNCT04967690
What this trial is testing

A Dose Escalation Study to Estimate MTD, DLTs and Pharmacokinetics After a Single Intracranial Dose of SI-053 as an add-on to the Current Standard of Care, in Adult Patients With Newly Diagnosed GBM

Who this might be right for
Newly Diagnosed Glioblastoma
Double Bond Pharmaceutical AB 27
Testing effectiveness (Phase 2)Study completedNCT01591577
What this trial is testing

Lapatinib With Temozolomide and Regional Radiation Therapy for Patients With Newly-Diagnosed Glioblastoma Multiforme

Who this might be right for
Newly Diagnosed Glioblastoma Multiforme
Jonsson Comprehensive Cancer Center 50
Testing effectiveness (Phase 2)Looking for participantsNCT06012695
What this trial is testing

NBM-BMX Administered Orally to Patients With Solid Tumors or Newly Diagnosed Glioblastoma

Who this might be right for
Malignant NeoplasmMalignant Neoplasm of Brain
Novelwise Pharmaceutical Corporation 79
Early research (Phase 1)Study completedNCT03451799
What this trial is testing

Ketogenic Diet in Combination With Standard-of-care Radiation and Temozolomide for Patients With Glioblastoma

Who this might be right for
GBMGlioblastoma
Jethro Hu 21
Testing effectiveness (Phase 2)Study completedNCT00165477
What this trial is testing

Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
GlioblastomaGliosarcomaMalignant Gliomas
Dana-Farber Cancer Institute 23
Not applicableStudy completedNCT00704808
What this trial is testing

Post Marketing Surveillance: Newly Diagnosed Glioblastoma Multiforme Treated With Radiotherapy/Temozolomide and Adjuvant Temozolomide (Study P04739)

Who this might be right for
Glioblastoma
Merck Sharp & Dohme LLC 180
Early research (Phase 1)Study completedNCT02149225
What this trial is testing

GAPVAC Phase I Trial in Newly Diagnosed Glioblastoma Patients

Who this might be right for
Glioblastoma
Immatics Biotechnologies GmbH 16
Not applicableStudy completedNCT00999622
What this trial is testing

Study of Blood Samples and Risk of Infection in Patients With Newly Diagnosed Malignant Supratentorial Astrocytoma

Who this might be right for
Brain and Central Nervous System TumorsInfection
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 104
Large-scale testing (Phase 3)Study completedNCT00943826
What this trial is testing

Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma

Who this might be right for
Glioblastoma
Hoffmann-La Roche 921
Not applicableLooking for participantsNCT06964815
What this trial is testing

Silibinin in Association With Concomitant Chemoradiotherapy and Maintenance Temozolomide in STAT3 Positive IDH Wild-type, Newly Diagnosed Glioblastoma Patients

Who this might be right for
GlioblastomaIDH Wild-type and STAT3-positive Glioblastoma
Istituto Oncologico Veneto IRCCS 110
Early research (Phase 1)Study completedNCT00316849
What this trial is testing

Temsirolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma
National Cancer Institute (NCI) 56
Testing effectiveness (Phase 2)Study completedNCT00003996
What this trial is testing

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Who this might be right for
Brain and Central Nervous System Tumors
Alliance for Clinical Trials in Oncology 93
Early research (Phase 1)Study completedNCT01849146
What this trial is testing

Adavosertib, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed or Recurrent Glioblastoma

Who this might be right for
GlioblastomaRecurrent Glioblastoma
National Cancer Institute (NCI) 74
Testing effectiveness (Phase 2)Study completedNCT01790503
What this trial is testing

A Phase 1b/2 Study of PLX3397 + Radiation Therapy + Temozolomide in Patients With Newly Diagnosed Glioblastoma

Who this might be right for
Patients With Newly Diagnosed Glioblastoma
Daiichi Sankyo 65
Not applicableUnknownNCT03869242
What this trial is testing

NovoTTF-200A Together With Radiation Therapy and Temozolomide in Patients With Newly Diagnosed GBM

Who this might be right for
Glioblastoma
Tel-Aviv Sourasky Medical Center 60
Testing effectiveness (Phase 2)Looking for participantsNCT06595186
What this trial is testing

JK-1201I Combined with Adjuvant Temozolomide in Patients with Newly Diagnosed Glioblastoma Multiforme (GBM)

Who this might be right for
Glioblastoma Multiforme (GBM)
JenKem Technology Co., Ltd. 25
Large-scale testing (Phase 3)WithdrawnNCT04105374
What this trial is testing

Testing the Addition of an Anti-cancer Viral Gene Therapy, Toca 511/Toca FC, to the Usual Treatment (Temozolomide and Radiation Therapy) for Newly Diagnosed Glioblastoma

Who this might be right for
Anaplastic AstrocytomaGlioblastomaOligodendroglioma+1 more
NRG Oncology
Next Page